Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Vogelstein, B

Class:Id	Person:2500266
_displayName	Vogelstein, B
_timestamp	2012-10-01 20:30:04
created	[InstanceEdit:2500284] Orlic-Milacic, M, 2012-10-01
firstname	B
initial	B
surname	Vogelstein
(author)	[LiteratureReference:2500277] Securin is required for chromosomal stability in human cells [LiteratureReference:3318552] Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer [LiteratureReference:3640895] Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers [LiteratureReference:3642171] Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability [LiteratureReference:5575588] Founding mutations and Alu-mediated recombination in hereditary colon cancer [LiteratureReference:5633461] Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53 [LiteratureReference:5633467] Amplification of a gene encoding a p53-associated protein in human sarcomas [LiteratureReference:5638317] Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification [LiteratureReference:6803862] 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression [LiteratureReference:6803870] 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage
[Change default viewing format]

No pathways have been reviewed or authored by Vogelstein, B (2500266)